Self-care and self-medication as central components of healthcare in Germany - on the way to evidence-based pharmacy

被引:9
作者
Bertsche, Thilo [1 ,2 ,3 ]
Alexa, Jennifer Maria [1 ,2 ,3 ]
Eickhoff, Christiane [4 ]
Schulz, Martin [4 ,5 ,6 ]
机构
[1] Univ Leipzig, Inst Pharm, Med Fac, Clin Pharm Dept, Leipzig, Germany
[2] Univ Leipzig, Med Fac, Drug Safety Ctr, Leipzig, Germany
[3] Leipzig Univ Hosp, Leipzig, Germany
[4] ABDA Fed Union German Assoc Pharmacists, Dept Med, Berlin, Germany
[5] Free Univ Berlin, Inst Pharm, Berlin, Germany
[6] ABDA Fed Union German Assoc Pharmacists, Dept Med, Heidestr 7, D-10557 Berlin, Germany
来源
EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY | 2023年 / 9卷
关键词
Self-care; Community pharmacy services; Health policy; Primary care services; Pharmacist; Health services; OVER-THE-COUNTER; DRUG-RELATED PROBLEMS; SAFE USE; APPROPRIATE;
D O I
10.1016/j.rcsop.2023.100257
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In Germany, self-care is, above all interpreted as the prevention and treatment of minor injuries and illnesses by the patients themselves - that is, without a physician's prescription or medical advice. Maintaining one's health in the sense of a preventive approach through non-medicinal measures also plays an important role. Self-medication in this context is the treatment with approved over-the-counter-(OTC)-medications. In addition, other OTC-products such as dietary supplements as well as complementary and alternative medicines including homeopathic medications are frequently requested options by pharmacy customers. OTC-medications are central components of the German healthcare system, with expert advice from pharmacists in community pharmacies (CP) enabling safe and effective treatment. Additionally, screening for appropriate self-medication by pharmacists ensures that serious illnesses receive timely medical attention.In addition to prescribed medication, self-medication is an important part of the CP business in Germany. In contrast to prescription products, the price of OTC-products is not regulated. As a consequence, the price of OTC-products (including also pharmacy-only drugs) is influenced by competition among CPs and mail-order pharmacies, respectively. The sales of OTC-products for self-medication outside pharmacies, e.g. in drugstores and supermarkets, is restricted to a limited number of specific products.Evidence-based counseling in CPs, while generally advocated still remains a challenge. The evidence for the usage of OTC-products from clinical studies is not yet optimally integrated into everyday pharmacy practice. Information tools such as EVInews offering regular newsletters and a database have been developed to reduce the evidence-to-practice gap and to improve the overall counseling quality. Furthermore, the switching of drugs from prescription-only to pharmacy-only status also challenge CPs to provide adequate and updated guidance.
引用
收藏
页数:6
相关论文
共 37 条
[1]  
ABDA-Federal Union of German Associations of Pharmacists, 2023, For Pharmacists-Quality Assurance-Offers of the Chambers for Quality Assurance-Pseudo Customer
[2]  
ABDA-Federal Union of German Associations of Pharmacists, Pharmacy 2030-Perspectives on provision of pharmacy services in Germany.
[3]  
ABDA-Federal Union of German Associations of Pharmacists, Specialization Areas
[4]  
ABDA-Federal Union of German Associations of Pharmacists, 2022, Pharmacies can now Vaccinate Against Influenza.
[5]  
ABDA-Federal Union of German Associations of Pharmacists, Position Paper
[6]  
ABDA-Federal Union of German Associations of Pharmacists, German Pharmacies-Figures, Data, Facts
[7]  
[Anonymous], 2023, Commentary on the Guideline of the German Federal Chamber of Pharmacists on Quality Assurance
[8]  
[Anonymous], 2023, What is the Competition doing on the Net? Prices and Availability of OTC Products at MailOrder Companies
[9]  
[Anonymous], 2023, Ordinance on the Construction and Operation of Tramways (German: Verordnung uber den Bau und Betrieb der Strassenbahnen, BOStrab)
[10]  
[Anonymous], 2023, Joint Policy Statement of the Federation Internationale Pharmaceutique (FIP) and the GSCF on Responsible and Effective Self-Care.